Elevance Health trades at $423.06 per share and has stayed right on track with the overall market, losing 14% over the last ...

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (NYSE:ELV) with a Buy recommendation.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Over 90,000 patients face difficult decisions after Anthem Blue Cross Blue Shield and MU Health Care didn't reach a deal.

With a market cap of $102.5 billion, Elevance Health, Inc. (ELV ... and healthcare management services under brands such as Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon.

Shares of Apple and Tesla have lost more than 10% since “Liberation Day” during the stock market rollercoaster.

Investors on the lookout for stocks with the potential for maximum growth and value investing may consider the growth at a ...

Ekirch said specialists have suggested that a series of infusions made from blood plasma called intravenous immunoglobulin — ...

Most physicians surveyed expressed concern that health insurance companies’ use of AI is increasing prior authorization denials.